Bridging Therapy: Transitioning Between Blood Thinners Safely

15March
Bridging Therapy: Transitioning Between Blood Thinners Safely

Bridging Therapy Decision Tool

Is Bridging Therapy Necessary?

Answer these questions to determine if you need bridging therapy before surgery.

Why You Might Need to Switch Blood Thinners

If you’re on a blood thinner, you’ve probably heard the phrase "bridging therapy"-maybe from your doctor, or while preparing for surgery. But what does it really mean? And do you even need it? Bridging therapy is when you temporarily switch from one blood thinner to another-usually from warfarin to a shot like low molecular weight heparin (LMWH)-while you pause your usual medication for a procedure. The idea is simple: keep your blood from clotting too much during the gap, without making you bleed too much. But here’s the twist: for most people today, bridging isn’t needed anymore. The rules changed. A decade ago, doctors almost always bridged. Now, they rarely do. And the reason isn’t just a trend-it’s hard data from large clinical trials.

When Bridging Still Makes Sense

Not everyone is the same. Some people have a very high risk of clots. For them, stopping their blood thinner-even for a few days-could be dangerous. The only cases where bridging is still recommended are:
  • People with a mechanical heart valve in the mitral position
  • Those who had a blood clot in their lung or leg within the last 3 months
That’s it. That’s the entire list. Everything else? Probably not worth the risk. Why? Because the BRIDGE trial in 2015 showed something shocking: patients who were bridged had a 2.3% chance of major bleeding. Those who weren’t bridged? Just 1%. And guess what? The clot risk didn’t go down. No extra protection. Just more bleeding. If you have atrial fibrillation but no mechanical valve and no recent clot? You don’t need bridging. Ever.

How Warfarin Works (and Why It’s Complicated)

Warfarin is old. It’s been around for decades. It works by thinning your blood slowly, but it’s messy to manage. You need regular blood tests (INR checks). Your dose changes based on what you eat, what meds you take, even how much you sleep. When you’re getting ready for surgery, doctors stop warfarin 5 to 6 days before. Why? Because it takes that long for the effect to wear off. If you don’t wait, you could bleed too much during the procedure. But now you’re unprotected. So, in the past, they’d start injections-LMWH-3 days before surgery. That’s the classic bridge: stop warfarin → start shots → stop shots 24 hours before surgery → restart warfarin after. The problem? Those shots hurt. You have to inject yourself every day. You need to remember the timing. You need to store the medication properly. And you’re paying $300-$500 for a week’s supply in the U.S. And for most people? It’s unnecessary.

Why DOACs Changed Everything

Direct oral anticoagulants (DOACs)-like apixaban (Eliquis), rivaroxaban (Xarelto), and dabigatran (Pradaxa)-don’t need bridging. Not ever. Why? Because they work fast and leave fast. Warfarin sticks around for days. DOACs? They’re gone in 12 to 24 hours. That means:
  • You stop your DOAC the day before surgery (or even the morning of, depending on the procedure)
  • You don’t need shots
  • You restart it the day after surgery
No bridge. No injections. No extra cost. No risk of bleeding from extra anticoagulation. By 2023, 75% of new prescriptions for blood thinners were DOACs-not warfarin. That’s because they’re simpler, safer, and more predictable. And they’ve made bridging therapy nearly obsolete for the vast majority of patients. A split illustration showing a high-risk patient receiving a heparin injection versus a typical patient taking a simple pill, with symbolic elements.

The Real Risks of Bridging

Bridging isn’t harmless. It’s risky.
  • Bleeding: The BRIDGE trial showed a 2.3% major bleeding rate with bridging vs. 1% without. That’s more than double.
  • Logistics: You need to learn how to give yourself shots. You need to schedule appointments. You need to remember when to stop and start.
  • Cost: LMWH can cost $300-$500 for a week. Insurance doesn’t always cover it fully.
  • Adherence: Studies show 15-20% of patients miss at least one injection. That’s not just inconvenient-it’s dangerous.
And here’s the kicker: even if you do everything right, you’re still not safer from clots. You’re just more likely to bleed.

What to Do If You’re on Warfarin

If you’re still on warfarin and you need surgery or a procedure, here’s what actually works:
  1. Get your INR checked 5-7 days before the procedure. It should be under 2.0.
  2. Stop warfarin 5-6 days before surgery. No exceptions.
  3. Ask your doctor: "Am I in the 10-15% who actually need bridging?" If you don’t have a mechanical mitral valve or a recent clot, the answer is no.
  4. If you do need bridging, start LMWH 3 days before surgery. Stop it 24 hours before.
  5. After surgery, restart warfarin at 15-20% higher than your usual dose. Check your INR in 3-4 days.
And don’t forget: talk to your surgeon and your anticoagulation provider together. Miscommunication is the #1 cause of mistakes.

What to Do If You’re on a DOAC

If you’re on Eliquis, Xarelto, or Pradaxa, your plan is way simpler:
  • Stop the DOAC 1-2 days before surgery (check with your doctor-timing depends on kidney function and procedure type).
  • No injections. No bridging. No extra meds.
  • Restart the DOAC 12-24 hours after surgery, as long as bleeding is controlled.
You might need a quick INR check if you’re switching from warfarin to a DOAC. But you don’t need shots. You don’t need a bridge. You just need to follow the timing. An elderly person in a kitchen with pill bottles and a smiling heart, illustrating that DOACs eliminate the need for bridging therapy.

What If You’re Switching from Warfarin to a DOAC?

Sometimes, doctors switch patients from warfarin to a DOAC. That’s common. But the transition has rules.
  • Stop warfarin when your INR is below 2.0.
  • Start the DOAC the next day. No overlap. No bridging.
  • If your kidney function is low (creatinine clearance under 15 mL/min), you might need a longer gap between stopping warfarin and starting the DOAC.
Don’t just stop one and start the other on the same day. That’s dangerous. The timing matters.

Why the Guidelines Changed

In 2010, nearly half of patients on warfarin got bridged. By 2021, that number dropped to under 15%. Why? Because the evidence changed. The BRIDGE trial (2015) and the PERIOP2 trial (2020) showed that bridging doesn’t prevent strokes or clots-it just causes more bleeding. The American Heart Association, the American College of Cardiology, and the European Heart Rhythm Association all updated their guidelines to reflect this. Now, the rule is: only bridge if you’re at very high risk of clotting. Everything else? Skip it.

What You Should Ask Your Doctor

Don’t assume bridging is standard. Ask these questions:
  • "Am I at high risk for clots, or just at average risk?"
  • "Do I really need a bridge, or is this just how we used to do it?"
  • "What’s the bleeding risk if I don’t bridge?"
  • "Can we use a DOAC instead of warfarin so I don’t need this at all?"
Your doctor might say, "We’ve always done it this way." But that’s not good enough anymore. The science has moved on.

Final Thought: Less Is Often More

Blood thinners save lives. But more drugs, more shots, more complexity don’t always mean better outcomes. For most people, the safest path is simple: stop the blood thinner, do the procedure, restart the blood thinner. No bridge. No extra risk. If you’re on warfarin and you’re scheduled for surgery, ask your doctor: "Do I really need this?" If they say yes, ask why. If they can’t give you a clear reason based on your specific risk, push back. Because sometimes, the best medical decision isn’t adding something-it’s leaving something out.

Do all blood thinners need bridging before surgery?

No. Only warfarin sometimes needs bridging, and even then, only for a small group of high-risk patients-those with mechanical mitral valves or recent blood clots. Direct oral anticoagulants (DOACs) like Eliquis, Xarelto, and Pradaxa do not require bridging because they leave the body quickly. Stopping and restarting them without a bridge is safe and standard practice.

Is bridging therapy still commonly used today?

No. Bridging therapy has dropped sharply since 2015. Before that, nearly half of warfarin patients received it. Now, only about 10-15% of patients qualify for bridging, based on strict guidelines. Most patients with atrial fibrillation or non-mitral mechanical valves are better off without it. DOACs have replaced warfarin in 75% of new prescriptions, and they eliminate the need for bridging entirely.

What are the risks of bridging therapy?

The biggest risk is major bleeding. The BRIDGE trial found a 2.3% chance of major bleeding with bridging versus 1% without. Other risks include pain from daily injections, high cost (up to $500 for a week), missed doses (15-20% of patients skip shots), and confusion over timing. In most cases, these risks aren’t offset by any reduction in clotting events.

How long should I stop warfarin before surgery?

Stop warfarin 5 to 6 days before surgery. This allows your INR (blood clotting measure) to drop below 2.0, reducing bleeding risk. If you need bridging, start low molecular weight heparin (LMWH) 3 days before surgery and stop it 24 hours before the procedure. Always check your INR before stopping warfarin to confirm it’s in a safe range.

Can I switch from warfarin to a DOAC to avoid bridging?

Yes, and it’s often recommended. Switching from warfarin to a DOAC like Eliquis or Xarelto eliminates the need for bridging in most cases. To switch safely, stop warfarin when your INR is below 2.0, then start the DOAC the next day. No overlap, no injections. This approach is simpler, safer, and cheaper long-term. Talk to your doctor if you’re on warfarin and scheduled for surgery-this might be a better option for you.